Related Experiment Videos
Lactulose--a drug with antiendotoxin effect
Hepato-Gastroenterology
|October 1, 1980
Summary
Lactulose demonstrated anti-endotoxin properties by preventing liver damage in rats. This suggests lactulose may be a therapeutic option for conditions involving endotoxemia.
Area of Science:
- Pharmacology
- Gastroenterology
- Hepatology
Background:
- Systemic endotoxemia, originating from the gut, contributes to liver damage.
- Galactosamine administration in rats induces liver necrosis mediated by endotoxemia.
Purpose of the Study:
- To investigate the anti-endotoxin properties of lactulose.
- To evaluate lactulose's efficacy in preventing galactosamine-induced liver injury in vivo.
Main Methods:
- In vitro testing of lactulose's effect on E. coli endotoxin using Limulus lysate.
- Oral administration of lactulose to rats for 4-8 days prior to galactosamine injection.
Main Results:
- Lactulose abolished the gelating activity of E. coli endotoxin in vitro.
- Lactulose administration prevented galactosamine-induced liver damage and necrosis in rats.
Conclusions:
- Lactulose exhibits significant anti-endotoxin effects both in vitro and in vivo.
- Lactulose shows therapeutic potential for clinical conditions associated with endotoxemia, including liver diseases and sepsis.